Shree Ganesh Remedies Ltd. engages in the research, development, manufacture, and marketing of healthcare products. The company is headquartered in Ankleshwar, Gujarat. The company went IPO on 2017-10-13. The firm is a supplier of pharmaceutical intermediates and specialty chemicals with chlorination, Grignard reaction, hydrogenation, and high-vacuum distillation. The firm's products include intermediates by active pharmaceutical ingredient (API), and fine and specialty chemicals. The company offers services, including customized chemistry and manufacturing, assets and infrastructure and key technologies and expertise. The company offers its solutions to the markets, such as life sciences: human health and veterinary, flavor and fragrance, polymer industries, electronics, and agro chemicals. The firm has an extensive portfolio of approximately 39 drug intermediates, and 18 specialty chemical products. The company also delivers a service of contract manufacturing for chemical reactions like amination, amidation, alkylation, bromination, catalytic hydrogenation and chlorination.

Shree Ganesh Dividends

540737.BO dividend metrics

Dividend per share

540737.BO dividend history